RU94010496A - Nootropic agent and medicinal composition of nootropic agent - Google Patents

Nootropic agent and medicinal composition of nootropic agent

Info

Publication number
RU94010496A
RU94010496A RU94010496/14A RU94010496A RU94010496A RU 94010496 A RU94010496 A RU 94010496A RU 94010496/14 A RU94010496/14 A RU 94010496/14A RU 94010496 A RU94010496 A RU 94010496A RU 94010496 A RU94010496 A RU 94010496A
Authority
RU
Russia
Prior art keywords
agent
nootropic agent
nootropic
heptapeptide
pro
Prior art date
Application number
RU94010496/14A
Other languages
Russian (ru)
Other versions
RU2045958C1 (en
Inventor
Л.А. Андреева
И.П. Ашмарин
А.А. Каменский
Н.Ф. Мясоедов
В.Н. Незавибатько
Т.В. Рясина
Original Assignee
Институт молекулярной генетики РАН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт молекулярной генетики РАН filed Critical Институт молекулярной генетики РАН
Priority to RU94010496/14A priority Critical patent/RU2045958C1/en
Application granted granted Critical
Publication of RU2045958C1 publication Critical patent/RU2045958C1/en
Publication of RU94010496A publication Critical patent/RU94010496A/en

Links

Abstract

FIELD: medicine, pharmacy. SUBSTANCE: invention proposes heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as a nootropic agent. The proposed nootropic agent has heptapeptide (0.95-1.05 g/l) as an active component, preserving agent nipagin (0.9501.05 g/l) and distilled water - the rest. Agent is used as nasal drops. EFFECT: high effectiveness of agent at low doses, simplified use.

Claims (1)

Изобретение используется в медицине. Сущность изобретения: применение гептапептида Met-Glu-His-Phe-Pro-Gly-Pro в качестве ноотропного средства. Предложен новый состав ноотропного средства, содержащий активное вещество в виде гептапептида (0,95-1,05 г/л), консервант в виде нипагина (0,95-1,05 г/л) и вода дистиллированная остальное. Состав высокоэффективен в низких дозах и прост в применении: используется в виде капель в нос.The invention is used in medicine. The inventive use of the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as a nootropic agent. A new composition of a nootropic agent is proposed, containing the active substance in the form of a heptapeptide (0.95-1.05 g / l), a preservative in the form of nipagin (0.95-1.05 g / l), and the rest is distilled water. The composition is highly effective in low doses and easy to use: used in the form of drops in the nose.
RU94010496/14A 1994-03-28 1994-03-28 Nootropic drug and pharmaceutical nootropic composition RU2045958C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94010496/14A RU2045958C1 (en) 1994-03-28 1994-03-28 Nootropic drug and pharmaceutical nootropic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94010496/14A RU2045958C1 (en) 1994-03-28 1994-03-28 Nootropic drug and pharmaceutical nootropic composition

Publications (2)

Publication Number Publication Date
RU2045958C1 RU2045958C1 (en) 1995-10-20
RU94010496A true RU94010496A (en) 1997-05-10

Family

ID=20153986

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94010496/14A RU2045958C1 (en) 1994-03-28 1994-03-28 Nootropic drug and pharmaceutical nootropic composition

Country Status (1)

Country Link
RU (1) RU2045958C1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2431496C2 (en) * 2009-09-15 2011-10-20 Общество С Ограниченной Ответственностью "Герофарм" Injection dosage form for treating acute ischemic stroke and craniocereberal injury, method for preparing and using
DE202010008608U1 (en) 2010-09-22 2010-11-25 Obshchestvo S Ogranichennoj Otvetstvennost'yu "Mediko-Pharmacevticheskoe Predpriyatie "Vatros" The pharmaceutical composition
RU2638270C2 (en) * 2016-05-19 2017-12-12 Объединенный Институт Ядерных Исследований Method for prevention of neurological status and muscular tonus violations in acute radiation disease in experiment

Also Published As

Publication number Publication date
RU2045958C1 (en) 1995-10-20

Similar Documents

Publication Publication Date Title
DK0458894T3 (en) Lipid excipients for nasal delivery and topical application
RU97115893A (en) LOCAL APPLICATION
RU95105887A (en) Cosmetic filtering compositions and their use
RU94041223A (en) Agent for motoneuron disease treatment
AR018526A1 (en) PHARMACEUTICAL COMPOSITION NOT LIOFILIZED IN THE FORM OF A SOLUTION THAT INCLUDES HUMAN PARTIROID HORMONE, PROCESS TO PREPARE A FLASK OR CARTRIDGE CONTAINING IT, PROCESS TO PREPARE SUCH COMPOSITION, BOTTLE OR CARTRIDGE THAT CONTAINS THE COMPOSITION OF THE COMPOSITION OF THE COMPOSITION
PT723437E (en) PHARMACEUTICAL PREPARATION BY MULTIPLE UNITS CONTAINING AN INHIBITOR OF THE PUMP PUMP
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
ATE184473T1 (en) USE OF GLYCERINE TO ATTENUATE TRANSDERMAL DRUG ADMINISTRATION
ES2117642T3 (en) PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETILEN GLYCOLS.
ES2145913T3 (en) METALOPROTEASE INHIBITORS.
SE8300736D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
CO5150202A1 (en) COMPOSITION OF FACIAL TISSU AND METHOD FOR USE FOR THE SECRETARY OF SKIN IRRITANTS OF THE NASAL SECRETION
DE69431533T2 (en) DOSAGE FORM FOR ADMINISTRATION OF LIQUID MEDICINAL FORMULATION
ATE15596T1 (en) PHARMACEUTICAL AGENT.
FR2541115B1 (en) MEDICAMENT CONTAINING PEPTIDE AS ACTIVE INGREDIENT FOR THE TREATMENT OF ULCEROUS CONDITIONS
RU94010496A (en) Nootropic agent and medicinal composition of nootropic agent
FI962056A0 (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active ingredient comprising a combination of acetylsalicylic acid and metoclopramide
FR2687915B1 (en) PHARMACEUTICAL COMPOSITION FOR USE AS ANALGESIC CONTAINING ACID (BENZOYL-3 PHENYL) -2 PROPIONIC- (R).
KR920703060A (en) Pharmaceutical Formulations
ES2031462T3 (en) PROCEDURE TO PRODUCE 1-B-D-ARABINOFURANOSILCITOSINA-5'-STERARILFOSFATO MONOSODICO AND MONOHIDRATO OF THE SAME, AND PHARMACEUTICAL COMPOUND THAT CONTAINS THIS LAST.
RU94032792A (en) Application of 5htia-antagonists for tobacco use stopping
KR910004186A (en) Pharmaceutical Formulations
JPS5724308A (en) Anti-inflammatory and analgesic plaster
CA2113080A1 (en) Topical composition containing penciclovir
FR2754824B1 (en) NEW COMPOSITION CONTAINING CHITOSAN

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Effective date: 20051021